That estimate alone should be enough to drive the goal of routine genomic screening in healthcare forward, a researcher wrote in the Annals of Internal Medicine, but hurdles remain with implementing that plan into clinical care.

Healthcare advocacy groups expressed concern with the Trump administration’s final rule on short-term insurance plans, saying the decision to extend those limited plans for up to three years could destabilize other insurance markets and leave patients covered by such plans exposed to catastrophic costs.

A protein known to protect brain function in the setting of Duchenne muscular dystrophy may also have a positive impact on the heart, according to preliminary research presented at the American Heart Association’s Basic Cardiovascular Sciences scientific sessions on Aug. 1 in San Antonio.

Continually updated mortality models based on adverse events and end-organ function are better at showing which transplant candidates most urgently require a new heart, according to a study published in the Journal of the American College of Cardiology.

New analysis in the Journal of the American College of Cardiology notes an increase in the proportion of female senior and first authors in cardiology literature.

Researchers have developed an online tool to more accurately calculate which middle-aged individuals are at the highest risk of heart attack or stroke during the next 10 years.

A simple measure of waist circumference could identify chronic heart failure patients who would benefit most from mineralocorticoid receptor antagonists, according to a review published July 25 in JAMA Cardiology.

In following patients with heart failure for up to 15 years, Spanish cardiologists found left ventricular ejection fraction (LVEF) followed an inverse U-shape: LVEF improved for the first year, then plateaued for the rest of the first decade and declined in the following years—especially before death.

Rapid Medical has received CE mark approval for its Tigertriever 13 clot retriever, the smallest such device on the market which is designed to treat intracranial vessels between one and 2.5 millimeters.

Italian physicians reported what they believe to be “unprecedented clinical improvement” from interleukin-1 suppression in a patient with dilated cardiomyopathy.